Apoptosis Induction Through Proteasome Inhibition
A defining outcome of proteasome inhibition is the activation of apoptosis, or programmed cell death. This process allows the body to remove damaged or diseased cells in a controlled manner.
Accumulated proteins disrupt critical signaling pathways that regulate cell survival. This imbalance triggers apoptotic cascades involving mitochondrial dysfunction and activation of cell-death enzymes.
Unlike necrosis, apoptosis minimizes inflammation and tissue damage. This controlled elimination is particularly valuable in therapeutic settings where precision is essential.
By exploiting apoptosis pathways, ubiquitin proteasome drugs eliminate harmful cells while preserving surrounding tissue integrity.
1 View